Patin, Franck
Baranek, Thomas
Vourc'h, Patrick
Nadal-Desbarats, Lydie
Goossens, Jean-François
Marouillat, Sylviane
Dessein, Anne-Frédérique
Descat, Amandine
Hounoum, Blandine Madji
Bruno, Clément
Watier, Hervé
Si-Tahar, Mustafa
Leman, Samuel
Lecron, Jean-Claude
Andres, Christian R.
Corcia, Philippe
Blasco, Hélène
Funding for this research was provided by:
Fondation Brou de Laurières
Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone
This article is maintained by: Elsevier
Article Title: Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-016-0461-3
Content Type: article
Copyright: Copyright © 2016 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.